Available in English and Spanish, this e-newsletter separates fact from fiction on over 40 heart topics by Texas Heart Medical Group's Dr. Stephanie Coulter.
Texas Heart Institute (THI) conducts research through clinical trials as part of our mission to improve heart health. The trials conducted at THI are designed to test the safety and effectiveness of innovative new treatments and medications for patients.
Innovative Technologies & Techniques is produced at THI and explores promising advances in medicine that aim to extend the life of cardiac patients and patients at risk for series heart and vascular conditions. In response to the evolving pandemic, emerging topics related to COVID-19 are featured in the special Cardiology in the Time of COVID-19 episodes.
Our progress would not be possible without our donor community. Help support our mission by giving today.
Unlike areas with known evidence-based knowledge, the field of clinical regenerative medicine and stem cell therapy is a nascent field in which most of the competence and performance issues are unestablished. In the current landscape, as this field develops, it is important to share new findings, discuss and debate the state of the field in order to direct further development, and build the framework for its clinical implementation. This meeting provides an important forum for these activities.
The primary need for this educational activity is knowledge based – both the need for knowledge and the application of knowledge to establish successful strategies in clinical regenerative medicine. To achieve these goals, this symposium includes advanced lectures and dynamic case presentations from leaders in each field, as well as the opportunity to interact with leaders in an intimate meeting format.